Efficacy and Safety of High-Dose Multimatrix Mesalazine in Pediatric Patients with Mild-to-Moderate Active Ulcerative Colitis
Authors:
- Toshiaki ShimizuToshiaki Shimizu
- Itaru IwamaItaru Iwama
- Toshihiko KakiuchiToshihiko Kakiuchi
- Daiki AbukawaDADaiki Abukawa
- Hideki KumagaiHideki Kumagai
- Naomi IwataNaomi Iwata
- Masahiro TakatsuMTMasahiro Takatsu
- Kanako NishimuraKNKanako Nishimura
- Akiko MatsudaAkiko Matsuda
- Koichi HayashiKHKoichi Hayashi
- Tatsuki MizuochiTatsuki Mizuochi
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 29 (3) , 220-231
Abstract
Shimizu T, et al. Pediatr Gastroenterol Hepatol Nutr. 2026 May;29(3):220-231. https://doi.org/10.5223/pghn.2026.29.3.220Keywords
Funding Information
- Mochida Pharmaceutical Co., LTD.
This publication has 20 references indexed in Scilit:
- Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2021
- Management of Paediatric Ulcerative Colitis, Part 1Journal of Pediatric Gastroenterology and Nutrition, 2018
- Quality Items Required for Running a Paediatric Inflammatory Bowel Disease Centre: An ECCO PaperJournal of Crohn's and Colitis, 2017
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current ManagementJournal of Crohn's and Colitis, 2017
- Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM TrialJournal of Crohn's and Colitis, 2016
- High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition, 2014
- Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis—A Global Scientific Discussion, Part 1Journal of Pediatric Gastroenterology and Nutrition, 2014
- Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative ColitisClinical Gastroenterology and Hepatology, 2007
- Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative ColitisGastroenterology, 2007
- Quantification of the placebo response in ulcerative colitisGastroenterology, 1997